KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gevo (GEVO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Gevo (GEVO) over the last 17 years, with Q3 2025 value amounting to $72.6 million.

  • Gevo's Cash & Equivalents fell 6747.79% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.6 million, marking a year-over-year decrease of 6747.79%. This contributed to the annual value of $189.4 million for FY2024, which is 3652.1% down from last year.
  • As of Q3 2025, Gevo's Cash & Equivalents stood at $72.6 million, which was down 6747.79% from $69.6 million recorded in Q2 2025.
  • Gevo's Cash & Equivalents' 5-year high stood at $525.3 million during Q1 2021, with a 5-year trough of $40.8 million in Q4 2021.
  • Its 5-year average for Cash & Equivalents is $198.8 million, with a median of $200.6 million in 2022.
  • In the last 5 years, Gevo's Cash & Equivalents soared by 555532.35% in 2021 and then crashed by 9150.5% in 2022.
  • Over the past 5 years, Gevo's Cash & Equivalents (Quarter) stood at $40.8 million in 2021, then soared by 480.72% to $237.1 million in 2022, then grew by 25.82% to $298.3 million in 2023, then tumbled by 36.52% to $189.4 million in 2024, then tumbled by 61.67% to $72.6 million in 2025.
  • Its Cash & Equivalents stands at $72.6 million for Q3 2025, versus $69.6 million for Q2 2025 and $65.3 million for Q1 2025.